Previous 10 | Next 10 |
2024-03-18 17:25:15 ET More on Delcath Systems Delcath Systems announces $7 million private placement Delcath Systems announces CMS established product-specific J-code for HEPZATO Seeking Alpha’s Quant Rating on Delcath Systems Read the full article ...
2024-03-15 09:01:04 ET More on Delcath Systems Delcath Systems announces CMS established product-specific J-code for HEPZATO Delcath launches Hepzato Kit in US for uveal melanoma Seeking Alpha’s Quant Rating on Delcath Systems Historical earnings data ...
Delcath Systems Announces $7 Million Private Placement PR Newswire NEW YORK , March 15, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today an...
Delcath Systems Announces Healthcare Setting Locator for HEPZATO™ KIT (melphalan/Hepatic Delivery System) PR Newswire NEW YORK , Feb. 22, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treat...
2024-01-31 09:14:13 ET More on Delcath Systems Adoption Of Delcath's Hepzato Kit Will Snowball Quicker Than The Market Expects Delcath Systems Inc. (DCTH) Q3 2023 Earnings Call Transcript Delcath launches Hepzato Kit in US for uveal melanoma Delcath Systems Q...
Delcath Systems Receives Permanent J-Code (J9248) for HEPZATO™ (melphalan/Hepatic Delivery System) Effective April 1, 2024 PR Newswire NEW YORK , Jan. 31, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company foc...
Delcath Systems to Participate in a Fireside Chat at the Lytham Partners 2024 Investor Select Conference PR Newswire NEW YORK , Jan. 23, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of ...
2024-01-16 09:43:50 ET More on Delcath Systems Adoption Of Delcath's Hepzato Kit Will Snowball Quicker Than The Market Expects Delcath Systems Inc. (DCTH) Q3 2023 Earnings Call Transcript Delcath Systems Q3 2023 Earnings Preview Seeking Alpha’s Quant R...
Delcath Systems Announces U.S. Launch and First Commercial Treatment Utilizing HEPZATO KIT™ PR Newswire NEW YORK , Jan. 16, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primar...
2023-12-19 10:11:12 ET Penny Stocks and Preparing for 2024 As we enter 2024, investors wonder if it will be another volatile year for stocks. Maybe we see some stabilization after 2023’s ups and downs; maybe not. For those interested in penny stocks, the high-risk but potentially...
News, Short Squeeze, Breakout and More Instantly...
Delcath Systems Inc. Company Name:
DCTH Stock Symbol:
OTCMKTS Market:
Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) PR Newswire NEW YORK , April 4, 2024 /PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary ...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
2024-03-27 09:15:03 ET Canaccord Genuity analyst issues BUY recommendation for DCTH on March 27, 2024 08:09AM ET. The previous analyst recommendation was Buy. DCTH was trading at $4.61 at issue of the analyst recommendation. The overall analyst consensus : BUY. Curre...